Signaling Pathways for UV-Induced Melanogenic Response
紫外线诱导的黑色素生成反应的信号通路
基本信息
- 批准号:7902757
- 负责人:
- 金额:$ 9.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-15 至 2010-08-14
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdenylate CyclaseAffectAgonistAllelesApoptosisApplications GrantsArrestinsBindingBiological AssayCell Surface ReceptorsCell membraneCell surfaceCellsChronicClathrin-Coated VesiclesCongenital MegacolonCorticotropinCountryCouplingCutaneousCyclic AMPCyclic AMP-Dependent Protein KinasesCyclic GMP-Dependent Protein KinasesDNA DamageDataDominant-Negative MutationEarly EndosomeElectron MicroscopyEndothelin B ReceptorEndothelin ReceptorEndothelin-1EpidermisFundingGTP-Binding ProteinsGene ExpressionGenerationsGenesGenetic PolymorphismGenetic TranscriptionGenetic VariationGenome StabilityGenotypeGoalsGrantHumanHydrogen PeroxideImmunoprecipitationIncidenceIndividualKineticsKnowledgeLabelLeadLigandsLysosomesMalignant - descriptorMeasuresMelanocortin 1 ReceptorMelanocyte stimulating hormoneMelanoma CellMembraneMembrane Protein TrafficMessenger RNAMolecularMonitorMutationNational Institute of Environmental Health SciencesNon-MalignantNucleotide Excision RepairOutcomeOxidative StressPathway interactionsPhenotypePhosphorylationPhosphotransferasesPhysiologic pulsePhysiologicalPigmentation physiologic functionPigmentsPlayPredispositionPrevention strategyProtein DephosphorylationProteinsProteolysisPublic HealthRadiationRadiation Induced DNA DamageReceptor ActivationReceptor GeneRecyclingRegulationReportingReverse Transcriptase Polymerase Chain ReactionRiskRisk FactorsRoleSignal PathwaySkin CancerSkin CarcinomaSkin tanningStudy SectionSurfaceSusceptibility GeneTestingTimeTranscriptional RegulationTransmembrane DomainUVB inducedUltraviolet RaysWestern Blottingadvanced diseaseagouti proteinalpha-Melanocyte stimulating hormonearrestin 1arrestin 2basebrief interventioncell typedesensitizationeffective therapyeumelaninexposed human populationhigh riskloss of functionmelanocortin receptormelanocytemelanomanovelparacrinephotoprotectionpreventprotein activationprotein expressionpublic health relevancereceptorreceptor bindingreceptor couplingreceptor expressionreceptor internalizationreceptor recyclingresearch studyresponsetrafficking
项目摘要
DESCRIPTION (provided by applicant): This competing renewal application aims at investigating the hypothesis that exposure of human melanocytes to ultraviolet radiation (UV) and/or the physiological agonist 1-melanocyte stimulating hormone (1-MSH) or antagonist agouti signaling protein (ASIP) modulates the expression of the melanocortin 1 receptor (MC1R) gene, and regulates the activation of the receptor by affecting its desensitization, internalization and resensitization. The MC1R is a Gs protein-coupled receptor with seven transmembrane domains that is expressed on human melanocytes. Activation of this receptor by its agonists 1-MSH or ACTH stimulates cAMP formation and the synthesis of the brown-black eumelanin, which confers cutaneous photoprotection. We have shown that activation of the MC1R is pivotal for the UV-induced tanning response, and importantly, reduces the extent of UV-induced DNA damage by enhancing nucleotide excision repair and counteracting oxidative stress in human melanocytes. These effects explain why loss-of-function alleles of the MC1R are associated with increased risk for melanoma. We are proposing that MC1R expression and function are regulated at different levels in response to UV, its physiological agonists and antagonist. To investigate the above stated hypothesis, we propose the following three Specific Aims. First, we will investigate the regulation of MC1R gene expression and receptor trafficking by real time RT-PCR, Western blotting, and immunostaining. Second, we will determine the activation of the MC1R, by quantitating the number of membrane receptors/melanocyte, its agonist-induced desensitization, internalization, and resensitization. Third, we will define the roles of G protein receptor kinases (GRKs) and 2-arrestins in MC1R surface expression and sequestration. The significance of the proposed studies lies in the critical role of the MC1R and melanocortins in the UV responses of human melanocytes, and in filling the gap in the existing knowledge about regulation of this receptor in the physiologically-relevant cell, the epidermal melanocyte. Given that the MC1R is a melanoma susceptibility gene and an important determinant of the UV-induced tanning response, elucidating the regulation of MC1R expression and activation will lead to new strategies to prevent melanoma and other types of skin cancer by increasing the activity of the MC1R and optimizing the photoprotective capacity of the melanocyte, particularly in high risk individuals. PUBLIC HEALTH RELEVANCE The outcome of this grant application is expected to lead to new strategies for prevention of melanoma, the deadliest form of skin cancer, and of non-melanoma skin cancers. These strategies will be based on modulating the activity of the melanocortin 1 receptor by mechanisms that will be elucidated during the course of this grant proposal. The incidence of melanoma in the U.S. and Eastern countries continues to rise with no effective treatment for advanced disease; hence the relevance of this project for public health.
描述(由申请人提供):这种竞争性更新申请旨在调查人类黑色素细胞暴露于紫外线辐射(UV)和/或生理激动剂1-甲状腺素刺激激素(1-MSH)或拮抗剂AGOUTI信号蛋白(ASIP)的表达1-甲虫的表达1-甲基素体(1-MSH)的表达,以下假设。通过影响其脱敏,内在化和敏化来激活受体。 MC1R是一种GS蛋白偶联受体,具有七个在人黑色素细胞上表达的跨膜结构域。该受体的激动剂1-MSH或ACTH激活该受体刺激cAMP的形成和棕色黑色eumelanin的合成,这使皮肤光保护赋予。我们已经表明,MC1R的激活对于紫外线诱导的晒黑反应是关键的,重要的是,通过增强核苷酸切除修复并抵消人类黑素细胞中氧化应激,从而降低了UV诱导的DNA损伤的程度。这些影响解释了为什么MC1R的功能丧失等位基因与黑色素瘤风险增加有关。我们提出,MC1R表达和功能是根据紫外线(其生理激动剂和拮抗剂)在不同水平下的调节。为了研究上述假设,我们提出以下三个特定目标。首先,我们将根据实时RT-PCR,Western blotting和Ammunosing研究MC1R基因表达和受体运输的调节。其次,我们将通过量化膜受体/黑素细胞的数量,其激动剂诱导的脱敏,内在化和脱敏化来确定MC1R的激活。第三,我们将定义G蛋白受体激酶(GRKS)和2-次素在MC1R表面表达和隔离中的作用。拟议研究的重要性在于MC1R和黑色素皮质素在人类黑色素细胞的UV反应中的关键作用,以及在现有的有关该受体在生理上相关的细胞中调节该受体的知识的空白,表皮黑素细胞。鉴于MC1R是黑色素瘤敏感性基因,并且是紫外线诱导的晒黑反应的重要决定因素,阐明了MC1R表达和激活的调节,将导致新的策略,以通过增加MC1R的活性,并优化高风险个体的光学保护能力,从而预防黑色素瘤和其他类型的皮肤癌。 公共卫生相关性预计该赠款申请的结果将导致预防黑色素瘤,最致命的皮肤癌和非黑色素瘤皮肤癌的新策略。这些策略将基于通过在本赠款建议过程中阐明的机制来调节黑素皮质1受体的活性。美国和东部国家的黑色素瘤发病率继续增加,没有有效治疗晚期疾病。因此,该项目与公共卫生的相关性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ZALFA ABDEL-MALEK其他文献
ZALFA ABDEL-MALEK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ZALFA ABDEL-MALEK', 18)}}的其他基金
Vitiligo topical treatment applying a potent, highly selective MC1R agonist
使用强效、高选择性 MC1R 激动剂进行白癜风局部治疗
- 批准号:
10759768 - 财政年份:2023
- 资助金额:
$ 9.85万 - 项目类别:
Targeting the Melanocortin 1 Receptor by Selective Small Analogs of α-Melanocortin for Melanoma Prevention
通过选择性α-黑皮质素小类似物靶向黑皮质素 1 受体预防黑色素瘤
- 批准号:
10474302 - 财政年份:2018
- 资助金额:
$ 9.85万 - 项目类别:
Targeting the Melanocortin 1 Receptor by Selective Small Analogs of α-Melanocortin for Melanoma Prevention
通过选择性α-黑皮质素小类似物靶向黑皮质素 1 受体预防黑色素瘤
- 批准号:
10265379 - 财政年份:2018
- 资助金额:
$ 9.85万 - 项目类别:
Targeting the Melanocortin 1 Receptor by Selective Small Analogs of α-Melanocortin for Melanoma Prevention
通过选择性α-黑皮质素小类似物靶向黑皮质素 1 受体预防黑色素瘤
- 批准号:
9898307 - 财政年份:2018
- 资助金额:
$ 9.85万 - 项目类别:
Melanoma prevention by MC1R selective small peptide analogs of alpha MSH
通过 MC1R 选择性 α MSH 小肽类似物预防黑色素瘤
- 批准号:
9105353 - 财政年份:2015
- 资助金额:
$ 9.85万 - 项目类别:
Melanoma prevention by MC1R selective small peptide analogs of alpha MSH
通过 MC1R 选择性 α MSH 小肽类似物预防黑色素瘤
- 批准号:
8958319 - 财政年份:2015
- 资助金额:
$ 9.85万 - 项目类别:
How p16 and MC1R mutations synergistically exacerbate melanoma risk.
p16 和 MC1R 突变如何协同加剧黑色素瘤风险。
- 批准号:
8652005 - 财政年份:2014
- 资助金额:
$ 9.85万 - 项目类别:
Impact of MC1R Functional Variants on the DNA Damage Response of Human Melanocyte
MC1R 功能变异对人黑素细胞 DNA 损伤反应的影响
- 批准号:
7730250 - 财政年份:2009
- 资助金额:
$ 9.85万 - 项目类别:
Impact of MC1R Functional Variants on the DNA Damage Response of Human Melanocyte
MC1R 功能变异对人黑素细胞 DNA 损伤反应的影响
- 批准号:
8462256 - 财政年份:2009
- 资助金额:
$ 9.85万 - 项目类别:
Impact of MC1R Functional Variants on the DNA Damage Response of Human Melanocyte
MC1R 功能变异对人黑素细胞 DNA 损伤反应的影响
- 批准号:
8274543 - 财政年份:2009
- 资助金额:
$ 9.85万 - 项目类别:
相似国自然基金
腺苷酸环化酶ADCY3调控鸡肌内脂肪沉积的作用及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
腺苷酸环化酶ADCY3调控鸡肌内脂肪沉积的作用及机制研究
- 批准号:32202656
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
腺苷酸环化酶ZmRPP13-LK3催化生成的cAMP在玉米耐高温胁迫中的作用机制解析
- 批准号:32171945
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
CUL3和ARIH1介导的腺苷酸环化酶异源敏化在吗啡依赖发生中的作用研究
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
灰霉菌腺苷酸环化酶调节光响应与致病性的机理研究
- 批准号:31972121
- 批准年份:2019
- 资助金额:58 万元
- 项目类别:面上项目
相似海外基金
Small Heat Shock Proteins in Human Airway Smooth Muscle Tone and Pathophysiology
人呼吸道平滑肌张力和病理生理学中的小热休克蛋白
- 批准号:
8903540 - 财政年份:2014
- 资助金额:
$ 9.85万 - 项目类别:
A 3D microperfusion model of autosomal dominant polycystic kidney disease
常染色体显性多囊肾病的 3D 微灌注模型
- 批准号:
8779922 - 财政年份:2014
- 资助金额:
$ 9.85万 - 项目类别:
Sex Gender Differences in Post Traumatic Stress Disorder
创伤后应激障碍的性别差异
- 批准号:
8682833 - 财政年份:2014
- 资助金额:
$ 9.85万 - 项目类别:
Animal models of membrane-targeted APP intracellular domain - Resubmission 01
膜靶向 APP 胞内结构域的动物模型 - 重新提交 01
- 批准号:
8512466 - 财政年份:2013
- 资助金额:
$ 9.85万 - 项目类别:
Animal models of membrane-targeted APP intracellular domain - Resubmission 01
膜靶向 APP 胞内结构域的动物模型 - 重新提交 01
- 批准号:
8665364 - 财政年份:2013
- 资助金额:
$ 9.85万 - 项目类别: